Cargando…

Epitope Binning of Novel Monoclonal Anti F1 and Anti LcrV Antibodies and Their Application in a Simple, Short, HTRF Test for Clinical Plague Detection

Mouse monoclonal antibodies were raised against plague disease biomarkers: the bacterial capsular protein fraction 1 (F1) and the low-calcium response—LcrV virulence factor (Vag). A novel tandem assay, employing BioLayer Interferometry (BLI), enabled the isolation of antibodies against four differen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mechaly, Adva, Vitner, Einat B., Levy, Yinon, Gur, David, Barlev-Gross, Moria, Sittner, Assa, Koren, Michal, Levy, Haim, Mamroud, Emanuelle, Fisher, Morly
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8001648/ https://www.ncbi.nlm.nih.gov/pubmed/33801490 http://dx.doi.org/10.3390/pathogens10030285

Ejemplares similares

Improved production of monoclonal antibodies against the LcrV antigen of Yersinia pestis using FACS-aided hybridoma selection
por: Sittner, Assa, et al.
Publicado: (2018)

Rapid Induction of Protective Immunity against Pneumonic Plague by Yersinia pestis Polymeric F1 and LcrV Antigens
por: Aftalion, Moshe, et al.
Publicado: (2023)

Glutathionylation of Yersinia pestis LcrV and Its Effects on Plague Pathogenesis
por: Mitchell, Anthony, et al.
Publicado: (2017)

Polymorphism in the Yersinia LcrV Antigen Enables Immune Escape From the Protection Conferred by an LcrV-Secreting Lactococcus Lactis in a Pseudotuberculosis Mouse Model
por: Daniel, Catherine, et al.
Publicado: (2019)

Pilot Study on the Use of DNA Priming Immunization to Enhance Y. pestis LcrV-Specific B Cell Responses Elicited by a Recombinant LcrV Protein Vaccine
por: Li, Wei, et al.
Publicado: (2013)

Interaction of the Yersinia pestis type III regulatory proteins LcrG and LcrV occurs at a hydrophobic interface
por: Matson, Jyl S, et al.
Publicado: (2002)

Vaccine Potential of a Recombinant Bivalent Fusion Protein LcrV-HSP70 Against Plague and Yersiniosis
por: Gupta, Ankit, et al.
Publicado: (2020)

Interaction of the Yersinia pestis type III regulatory proteins LcrG and LcrV occurs at a hydrophobic interface: correction
por: Matson, Jyl S, et al.
Publicado: (2002)

A DNA vaccine producing LcrV antigen in oligomers is effective in protecting mice from lethal mucosal challenge of plague
por: Wang, Shixia, et al.
Publicado: (2004)

Circumventing Y. pestis Virulence by Early Recruitment of Neutrophils to the Lungs during Pneumonic Plague
por: Vagima, Yaron, et al.
Publicado: (2015)

Host Iron Nutritional Immunity Induced by a Live Yersinia pestis Vaccine Strain Is Associated with Immediate Protection against Plague
por: Zauberman, Ayelet, et al.
Publicado: (2017)

Targeting of the Yersinia pestis F1 capsular antigen by innate-like B1b cells mediates a rapid protective response against bubonic plague
por: Levy, Yinon, et al.
Publicado: (2018)

Yersinia pestis Antigen F1 but Not LcrV Induced Humoral and Cellular Immune Responses in Humans Immunized with Live Plague Vaccine—Comparison of Immunoinformatic and Immunological Approaches
por: Feodorova, Valentina A., et al.
Publicado: (2020)

A Serological Snapshot of COVID-19 Initial Stages in Israel by a 6-Plex Antigen Array
por: Fisher, Morly, et al.
Publicado: (2021)

The Amino-Terminal Part of the Needle-Tip Translocator LcrV of Yersinia pseudotuberculosis Is Required for Early Targeting of YopH and In vivo Virulence
por: Ekestubbe, Sofie, et al.
Publicado: (2016)

Yersinia pestis Endowed with Increased Cytotoxicity Is Avirulent in a Bubonic Plague Model and Induces Rapid Protection against Pneumonic Plague
por: Zauberman, Ayelet, et al.
Publicado: (2009)

Improved Selective BIN Agar for a Better Rate of Yersinia pestis Isolation from Primary Clinical Specimens in Suspected Madagascar Plague Cases
por: Aftalion, Moshe, et al.
Publicado: (2021)

Inhalational Gentamicin Treatment Is Effective Against Pneumonic Plague in a Mouse Model
por: Gur, David, et al.
Publicado: (2018)

Disruption of the NlpD lipoprotein of the plague pathogen Yersinia pestis affects iron acquisition and the activity of the twin-arginine translocation system
por: Tidhar, Avital, et al.
Publicado: (2019)

Phage Therapy Potentiates Second-Line Antibiotic Treatment against Pneumonic Plague
por: Vagima, Yaron, et al.
Publicado: (2022)

Spike vs nucleocapsid SARS-CoV-2 antigen detection: application in nasopharyngeal swab specimens
por: Barlev-Gross, Moria, et al.
Publicado: (2021)

HSP70 Domain II of Mycobacterium tuberculosis Modulates Immune Response and Protective Potential of F1 and LcrV Antigens of Yersinia pestis in a Mouse Model
por: Batra, Lalit, et al.
Publicado: (2014)

The NlpD Lipoprotein Is a Novel Yersinia pestis Virulence Factor Essential for the Development of Plague
por: Tidhar, Avital, et al.
Publicado: (2009)

Interactions between Yersinia pestis V-antigen (LcrV) and human Toll-like receptor 2 (TLR2) in a modelled protein complex and potential mechanistic insights
por: Wei, Tiandi, et al.
Publicado: (2019)

Reporter-Phage-Based Detection and Antibiotic Susceptibility Testing of Yersinia pestis for a Rapid Plague Outbreak Response
por: Moses, Sarit, et al.
Publicado: (2021)

Early sensing of Yersinia pestis airway infection by bone marrow cells
por: Vagima, Yaron, et al.
Publicado: (2012)

A Recombinant Trivalent Fusion Protein F1–LcrV–HSP70(II) Augments Humoral and Cellular Immune Responses and Imparts Full Protection against Yersinia pestis
por: Verma, Shailendra K., et al.
Publicado: (2016)

Novel RNA Extraction Method for Dual RNA-seq Analysis of Pathogen and Host in the Early Stages of Yersinia pestis Pulmonary Infection
por: Israeli, Ofir, et al.
Publicado: (2021)

Quorum sensing affects virulence-associated proteins F1, LcrV, KatY and pH6 etc. of Yersinia pestis as revealed by protein microarray-based antibody profiling
por: Chen, Zeliang, et al.
Publicado: (2006)

Post-exposure protection of SARS-CoV-2 lethal infected K18-hACE2 transgenic mice by neutralizing human monoclonal antibody
por: Rosenfeld, Ronit, et al.
Publicado: (2021)

YopP-Expressing Variant of Y. pestis Activates a Potent Innate Immune Response Affording Cross-Protection against Yersiniosis and Tularemia
por: Zauberman, Ayelet, et al.
Publicado: (2013)

Correction: YopP-Expressing Variant of Y. pestis Activates a Potent Innate Immune Response Affording Cross-Protection against Yersiniosis and Tularemia
por: Zauberman, Ayelet, et al.
Publicado: (2014)

Correction: Yopp-Expressing Variant ofY. pestis Activates a Potent Innate Immune Response Affording Cross-Protection against Yersiniosis and Tularemia
por: Zauberman, Ayelet, et al.
Publicado: (2013)

Development of a HTRF® Kinase Assay for Determination of Syk Activity
por: Harbert, Christopher, et al.
Publicado: (2008)

Antiviral activity of glucosylceramide synthase inhibitors in alphavirus infection of the central nervous system
por: Avraham, Roy, et al.
Publicado: (2023)

Identification of sulfur components enhancing the anti-Candida effect of Lactobacillus rhamnosus Lcr35
por: Dausset, Caroline, et al.
Publicado: (2020)

LcrQ Coordinates with the YopD-LcrH Complex To Repress lcrF Expression and Control Type III Secretion by Yersinia pseudotuberculosis
por: Fei, Keke, et al.
Publicado: (2021)

Neutralizing Monoclonal Anti-SARS-CoV-2 Antibodies Isolated from Immunized Rabbits Define Novel Vulnerable Spike-Protein Epitope
por: Makdasi, Efi, et al.
Publicado: (2021)

Screening of an FDA-Approved Library for Novel Drugs against Y. pestis
por: Gur, David, et al.
Publicado: (2021)

rVSV-ΔG-SARS-CoV-2-S vaccine: repeated intramuscular (IM) toxicity, local tolerance, immunogenicity and biodistribution study in NZW rabbits
por: Rosner, Amir, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_aie9gdib4vpc53qguso36t1b0a